Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis-Reference-Cited by-同舟云学术

Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis

Published:2005-11 Issue:1-2 Volume:168 Page:111-117
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Mazzanti Benedetta,Biagioli Tiziana,Aldinucci Alessandra,Cavaletti Guido,Cavalletti Ennio,Oggioni Norberto,Frigo Maura,Rota Stefania,Tagliabue Elena,Ballerini Clara,Massacesi Luca,Riccio Paolo,Lolli Francesco

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference21 articles.

1. Mitoxantrone, a topoisomerase II inhibitor, induces apoptosis of B-chronic lymphocytic leukaemia cells;Bellosillo;Br. J. Haematol.,1998

2. The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system;Bert't Hart;Curr. Opin. Neurol.,2003

3. Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis;Cavaletti;J. Neuroimmunol.,2004

4. Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients;Chan;Clin. Exp. Immunol.,2005

5. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species;Deibler;Prep. Biochem.,1972

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitoxantrone, pixantrone and mitoxantrone (2-hydroxyethyl)piperazine are toll-like receptor 4 antagonists, inhibit NF-κB activation, and decrease TNF-alpha secretion in primary microglia;European Journal of Pharmaceutical Sciences;2020-11

2. Something Old, New, Borrowed, Blue;Clinical Neuropharmacology;2016-03

3. Differential targeting of immune-cells by Pixantrone in experimental myasthenia gravis;Journal of Neuroimmunology;2013-05

4. Cationic Liposomes Target Sites of Acute Neuroinflammation in Experimental Autoimmune Encephalomyelitis;Molecular Pharmaceutics;2009-04-06

5. Therapeutic targets for multiple sclerosis;Drugs of the Future;2009